New Developments in the Diagnosis and Therapy of Allergic Rhinitis

Özdemir, Öner; Elmas, Bahri

doi:10.21911/aai.5033

Cited by 2 publications

(2 citation statements)

References 47 publications

(59 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Allergic rhinitis is classified as the seasonal/ intermittent type in which the symptoms develop in the pollen season and last no more than four days a week or less than four weeks in total, and the persistent/perennial type in which the symptoms occur year-round and last more than four days a week or more than four weeks (4). Moreover, based on the severity of the symptoms, it is classified as the mild type in which both sleeping and daily school and working activities are regular and the severe type in which both sleeping and daily school and working activities are disturbed (4,12). Our study cases generally were of the mild, intermittent type having no allergic rhinitis-related sleeping disorders with regular school and work activities.…”

Section: Discussionmentioning

confidence: 88%

Is Allergic Rhinitis Associated With Enuresis Nocturna In Childhood ?

Yaşar

Yılmaz

Yüksel

2023

Clinical and Experimental Health Sciences

View full text Add to dashboard Cite

Introduction Allergic rhinitis is the most common form of non-infectious rhinitis and is manifested with the symptoms of nasal congestion, sneezing, nasal discharge, and itching. Primary enuresis nocturna is involuntary urination while asleep after five years, at which bladder control usually begins. Our objective was to evaluate the relationship between allergic rhinitis and primary enuresis nocturna in childhood in this research. Methods: We included 300 children with allergic rhinitis and 300 control cases between the age of 5 and 17 years. With allergic rhinitis cases, age, gender, body mass index percentile, other allergic disorders, allergic rhinitis diagnosis age, allergic rhinitis severity and distribution, presence of primary enuresis nocturna, and presence of primary enuresis nocturna in the family were recorded. Subjects with disorders causing enuresis were excluded from the study. Results: The mean age in the allergic rhinitis and control groups was 9,6±3,4 vs. 10,0±3,1 years, respectively (p=0,15). There was no statistical difference between the two groups in terms of gender, age, body mass index percentile, and primary enuresis nocturna presence in the family (p=0.29, p=0.15, p=0.46, p=0.17; respectively). Primary enuresis nocturna was significantly higher in allergic rhinitis cases (p=0.02). Primary enuresis nocturna was significantly higher in boys than in girls (p=0.007). There is a significant difference in age and gender between those with and without primary enuresis nocturna in allergic rhinitis groups (p=0,001, p=0.01, respectively). Conclusion: We conclude that as allergic rhinitis increases the incidence of primary enuresis nocturna and worsens the quality of life, its treatment should not be neglected.

show abstract

Section: Discussionmentioning

confidence: 88%

Is Allergic Rhinitis Associated With Enuresis Nocturna In Childhood ?

Yaşar

Yılmaz

Yüksel

2023

Clinical and Experimental Health Sciences

View full text Add to dashboard Cite

show abstract

“…In order to analyze the effects of NCS on the hypothalamic-pituitary-adrenal axis, 2-4 weeks of kinemometry was performed for their short-term effects, and 12 months of stadiometry was employed for their long-term effects ( 419 , 441 , 445 , 446 ). Although some studies have shown that beclomethasone dipropionate ( 447 ) and fluticasone furoate ( 445 ) sprays lead to growth suppression, mometasone furoate spray does not have any adverse effects on growth rate ( 448 ). However, some studies showed that beclometasone dipropionate nasal aerosol did not have any negative effects on the hypothalamic-pituitary-adrenal axis ( 449 ).…”

Section: Treatment Of Allergic Rhinitismentioning

confidence: 99%

Turkish Guidelines for Diagnosis and Treatment of Allergic Rhinitis (ART)

Ecevit¹,

Özcan²,

Can³

et al. 2021

TAO

View full text Add to dashboard Cite

Object: To prepare a national guideline for Otorhinolaryngologist who treat allergic rhinitis patients. Methods: The study was conducted by three authors, namely the writing support team. The support team made the study plan, determined the writing instructions, chose the subgroups including the advisory committee, the advisors for authors and the authors. A workshop was organized at the very beginning to explain the details of the study to the team. Advisors took the chance to meet their coworkers in their subgroups and determined the main headings and subheadings of the guideline, together with the authors. After key words were determined by the authors, literature search was done in various databases. The authors keep in touch with the advisors and the advisors with the advisory committee and the support group at every stage of the study. National and International published articles as well as the abstracts of unpublished studies, imperatively presented in National Congresses, were included in this guideline. Only Guideline and meta-analyses published in last seven years (2013-2017) and randomized controlled studies published in last two years (2015-2017) were included. After all work was completed by the subgroups, support team brought all work together and edited the article. Results: A detailed guideline about all aspects of allergic rhinitis was created. Conclusion: The authors believe that this guideline will enable a compact and up-to-date information on allergic rhinitis to healthcare professionals. This guideline is the first in the field of Otolaryngology in Turkey. It should be updated at regular intervals.

show abstract

New Developments in the Diagnosis and Therapy of Allergic Rhinitis

Cited by 2 publications

References 47 publications

Is Allergic Rhinitis Associated With Enuresis Nocturna In Childhood ?

Is Allergic Rhinitis Associated With Enuresis Nocturna In Childhood ?

Turkish Guidelines for Diagnosis and Treatment of Allergic Rhinitis (ART)

Contact Info

Product

Resources

About